The vitamin d metabolites in the pathogenesis and management of osteoporosis

R. G. Crilly, A. Horsman, Munro Peacock, B. E C Nordin

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Studies on post-menopausal osteoporotic patients indicate that 1,25-(OH)2D3 concentrations are no different from those in age-matched normal subjects and the data suggest that the malabsorption of calcium found in many osteoporotic patients cannot generally be attributed to low plasma 1,25-(OH)2D3 levels. The effects are discussed of three different therapies - sex hormones alone, vitamin D metabolites alone and a combination of both - on calcium balance and peripheral bone loss in treated compared with untreated osteoporotic patients. The results indicate that combined therapy with a vitamin D metabolite and an oestrogen is more effective in inhibiting the rate of bone resorption in post-menopausal osteoporosis than treatment with either agent used alone, and should be regarded as the treatment of choice at the present time. It is suggested that, using this regimen which is suitable for patients up to about 65 years of age, calcium supplementation is not required, provided daily calcium intake is reasonably adequate, and may even be undesirable by increasing the risk of hypercalcaemia.

Original languageEnglish (US)
Pages (from-to)337-348
Number of pages12
JournalCurrent Medical Research and Opinion
Volume7
Issue number5
DOIs
StatePublished - 1981
Externally publishedYes

Fingerprint

Vitamins
Osteoporosis
Calcium
Vitamin D
Postmenopausal Osteoporosis
Hypercalcemia
Gonadal Steroid Hormones
Therapeutics
Bone Resorption
Estrogens
Bone and Bones

Keywords

  • Cholecalciferols
  • Osteoporosis
  • Sex Hormones

ASJC Scopus subject areas

  • Medicine(all)

Cite this

The vitamin d metabolites in the pathogenesis and management of osteoporosis. / Crilly, R. G.; Horsman, A.; Peacock, Munro; Nordin, B. E C.

In: Current Medical Research and Opinion, Vol. 7, No. 5, 1981, p. 337-348.

Research output: Contribution to journalArticle

Crilly, R. G. ; Horsman, A. ; Peacock, Munro ; Nordin, B. E C. / The vitamin d metabolites in the pathogenesis and management of osteoporosis. In: Current Medical Research and Opinion. 1981 ; Vol. 7, No. 5. pp. 337-348.
@article{7fd8d2b90de74497b57fa0496891f3db,
title = "The vitamin d metabolites in the pathogenesis and management of osteoporosis",
abstract = "Studies on post-menopausal osteoporotic patients indicate that 1,25-(OH)2D3 concentrations are no different from those in age-matched normal subjects and the data suggest that the malabsorption of calcium found in many osteoporotic patients cannot generally be attributed to low plasma 1,25-(OH)2D3 levels. The effects are discussed of three different therapies - sex hormones alone, vitamin D metabolites alone and a combination of both - on calcium balance and peripheral bone loss in treated compared with untreated osteoporotic patients. The results indicate that combined therapy with a vitamin D metabolite and an oestrogen is more effective in inhibiting the rate of bone resorption in post-menopausal osteoporosis than treatment with either agent used alone, and should be regarded as the treatment of choice at the present time. It is suggested that, using this regimen which is suitable for patients up to about 65 years of age, calcium supplementation is not required, provided daily calcium intake is reasonably adequate, and may even be undesirable by increasing the risk of hypercalcaemia.",
keywords = "Cholecalciferols, Osteoporosis, Sex Hormones",
author = "Crilly, {R. G.} and A. Horsman and Munro Peacock and Nordin, {B. E C}",
year = "1981",
doi = "10.1185/03007998109114277",
language = "English (US)",
volume = "7",
pages = "337--348",
journal = "Current Medical Research and Opinion",
issn = "0300-7995",
publisher = "Informa Healthcare",
number = "5",

}

TY - JOUR

T1 - The vitamin d metabolites in the pathogenesis and management of osteoporosis

AU - Crilly, R. G.

AU - Horsman, A.

AU - Peacock, Munro

AU - Nordin, B. E C

PY - 1981

Y1 - 1981

N2 - Studies on post-menopausal osteoporotic patients indicate that 1,25-(OH)2D3 concentrations are no different from those in age-matched normal subjects and the data suggest that the malabsorption of calcium found in many osteoporotic patients cannot generally be attributed to low plasma 1,25-(OH)2D3 levels. The effects are discussed of three different therapies - sex hormones alone, vitamin D metabolites alone and a combination of both - on calcium balance and peripheral bone loss in treated compared with untreated osteoporotic patients. The results indicate that combined therapy with a vitamin D metabolite and an oestrogen is more effective in inhibiting the rate of bone resorption in post-menopausal osteoporosis than treatment with either agent used alone, and should be regarded as the treatment of choice at the present time. It is suggested that, using this regimen which is suitable for patients up to about 65 years of age, calcium supplementation is not required, provided daily calcium intake is reasonably adequate, and may even be undesirable by increasing the risk of hypercalcaemia.

AB - Studies on post-menopausal osteoporotic patients indicate that 1,25-(OH)2D3 concentrations are no different from those in age-matched normal subjects and the data suggest that the malabsorption of calcium found in many osteoporotic patients cannot generally be attributed to low plasma 1,25-(OH)2D3 levels. The effects are discussed of three different therapies - sex hormones alone, vitamin D metabolites alone and a combination of both - on calcium balance and peripheral bone loss in treated compared with untreated osteoporotic patients. The results indicate that combined therapy with a vitamin D metabolite and an oestrogen is more effective in inhibiting the rate of bone resorption in post-menopausal osteoporosis than treatment with either agent used alone, and should be regarded as the treatment of choice at the present time. It is suggested that, using this regimen which is suitable for patients up to about 65 years of age, calcium supplementation is not required, provided daily calcium intake is reasonably adequate, and may even be undesirable by increasing the risk of hypercalcaemia.

KW - Cholecalciferols

KW - Osteoporosis

KW - Sex Hormones

UR - http://www.scopus.com/inward/record.url?scp=0019798886&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019798886&partnerID=8YFLogxK

U2 - 10.1185/03007998109114277

DO - 10.1185/03007998109114277

M3 - Article

C2 - 6894417

AN - SCOPUS:0019798886

VL - 7

SP - 337

EP - 348

JO - Current Medical Research and Opinion

JF - Current Medical Research and Opinion

SN - 0300-7995

IS - 5

ER -